One of the companies in Friday's NYSE Stocks in the News is Valeant Pharmaceuticals (VRX) which makes meds for skin and neurological disorders. It's shown three upside weeks in heavier-than-normal volume. .• Valeant is a small cap that trades a little over 1.2 million shares per day.• Fund ownership grew in each of the past three quarters.• Earnings grew at a triple-digit rate in each of the past three quarters. Sales growth has been somewhat erratic, though. You'd like to see sales growth continue to improve.• Valeant is showing some good measures of operational efficiency. Return on equity is strong, at 275, and so is cash flow per share, at $1.85.• Valeant's Accumulation/Distribution Rating is A, showing good buying in the past 13 weeks.
Sent from a BlackBerry
Friday, May 22, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment